DanielPPetroMD

Oncology • Pittsburgh, PA

Physician

Join to view full profile

Dr. Petro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Petro's full profile

Already have an account?

Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232
Phone+1 412-235-1020

Fax+1 412-235-1030

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2003 - 2006
UPMC Medical EducationResidency, Internal Medicine, 2000 - 2003
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2000

Certifications & Licensure

PA State Medical License 2001 - 2024
OH State Medical License 2006 - 2012
WV State Medical License 2006 - 2009
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Publications & Presentations

PubMed

15 citations
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T Ruffin, Carly Reeder
Clinical Cancer Research. 2022-04-01
30 citations
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard Joseph Appleman, Jan H. Beumer, Yixing Jiang, Yan Lin, Fei Ding
Cancer Chemotherapy and Pharmacology. 2019-12-01
50 citations
SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (...
Martin J. Edelman, Mary W. Redman, Kathy S. Albain, Eric C. McGary, Noman M. Rafique
Journal of Thoracic Oncology. 2019-10-01

Press Mentions

Lung-Sparing Surgery May Boost Mesothelioma SurvivalFebruary 14th, 2017